Sarepta Therapeutics ( NASDAQ: SRPT) faces an “arduous and treacherous path” to bring its gene therapy Elevidys back to market, according to a STAT report citing a senior FDA official, suggesting the ...

HF Sinclair downgraded at Piper Sandler, in a reflection of a more balanced risk/reward and a shift in preference towards the ...

Discover why UPS, with a 6.6% dividend yield, buybacks, and growth potential in automation, may be a lucrative opportunity ...

UniCredit (UNCFF) (UNCRY) has withdrawn its offer to buy Banco BPM (BNCZF), it said on Tuesday, after failing to secure ...

Mohawk Industries, Inc. struggles with revenue declines and macro headwinds despite cost-cutting efforts. Click for my updated look at MHK stock ahead of earnings.

Nissan's recovery focuses on cost cutting, plant closures, and a pivot to hybrid technology to regain competitiveness. Read ...

Lattice Semiconductor's strong balance sheet, no debt, and active share repurchases provide flexibility for reinvestment and ...

The withdrawal comes after Italian lender UniCredit ( OTCPK:UNCFF) offered to acquire smaller local rival Banco BP M ( ...

Johnson & Johnson's stock offers value with promising MedTech growth, raised guidance, strong dividends, and bullish ...

Q2 2025 Earnings Conference Call July 22, 2025 8:30 AM ET. Company Participants. Herbert C. Nappier - Executive VP & CFO Timothy Walsh - Senior Di ...

Discover Volaris' Q2 2025 earnings insights: resilience, 28% EBITDAR margin, loyalty program launch, and capacity strategies.

RTX reported adjusted earnings per share of $1.56, beating analysts’ consensus estimate of $1.43. Revenue for the quarter ...